Abstract:Abstract Background: Colorectal cancer (CRC) remains a prevalent malignancy worldwide with a high mortality rate. Over the last decade, the roles of several types of noncoding RNAs in oncogenesis have been clarified. Emerging evidence indicates that not only microRNAs, but small nucleolar RNAs (snoRNAs) appear to be dysregulated in various malignancies and they play a critical role in modulating cell transformation, tumor progression and metastasis. Functionally, cancer associated snoRNAs are subdivided into four major categories based on their oncogenic functions: 1) an independent function from imprinting gene in cancer initiation and progression 2) Activation of human telomerase 3) Inhibition of ribosomal maturation 4) Act directly as oncogene or tumor suppressor. Despite these exciting evidences, the role of snoRNAs in CRC remains limited and their clinical significance remains largely unexplored in this malignancy. Aims: We aimed to clarify the clinical relevance of snoRNAs in tumors and evaluate their prognostic potential in CRC. Furthermore, we investigated the functional role of snoRNAs in CRC tumorigenesis. Methods: Initially, we screened for the most commonly differentially expressed snoRNAs from publicly available microarray and RNA-sequence databases for other malignancies. Three clinical cohorts (a total 345 CRC tissues) were then used to select/validate the candidate snoRNAs. The prognostic potential of the candidate snoRNAs were evaluated and the association with clinicopathological features were assessed. CRISPR/Cas9 system was used to knockdown the target snoRNA in multiple CRC cell lines to determine the functional role of the target snoRNA in a series of in vitro assays. Results: In the discovery phase, we identified four differentially overexpressed snoRNAs in human cancers. We then confirmed overexpression of three snoRNAs (SNORA21, SNORA34 and SNORD66) in CRC compared to adjacent normal tissues. Of these three snoRNAs, high SNORA21 expression in tumors resulted in poor prognosis (p = 0.0086, Log-rank test). In an independent validation cohort, we confirmed high SNORA21 expression results in poor overall survival (p = 0.0060), especially in stage IV CRC (p = 0.0272). Clinicopathological analysis showed positive association between SNORA21 and vascular invasion and metastasis (p = 0.030 and 0.011, by Kruskal-Wallis test and Mann-Whitney U test, respectively) indicating that SNORA21 could be involved in metastasis. Moreover, multivariate analysis revealed that increased SNORA21 expression was an independent prognostic factor for overall survival. Using CRISPR/Cas9 stable SNORA21 knocked-down cell lines, we demonstrated that SNORA21 suppression resulted in reduced cell proliferation and colony forming capacity. Conclusion: We firstly identified SNORA21 as a novel oncogene which could also be a potential prognostic marker in patients with CRC. Citation Format: Kazuhiro Yoshida, Shusuke Toden, Wenhao Weng, Takeshi Nagasaka, Toshiyoshi Fujiwara, Ajay Goel. Clinical significance of SNORA21, an H/ACA box snoRNA, as a metastasis predicting and prognostic biomarker in colorectal cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 4926.

SNORA71A Promotes Colorectal Cancer Cell Proliferation, Migration, and Invasion

SNORA21 - An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer.

Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer

SnoRNAs Are Involved in the Progression of Ulcerative Colitis and Colorectal Cancer

Small nucleolar RNA and its potential role in the oncogenesis and development of colorectal cancer

Abstract 4926: Clinical Significance of SNORA21, an H/ACA Box Snorna, As a Metastasis Predicting and Prognostic Biomarker in Colorectal Cancer

SNORD15B and SNORA5C: Novel Diagnostic and Prognostic Biomarkers for Colorectal Cancer

Small Nucleolar RNA 71A Promotes Lung Cancer Cell Proliferation, Migration and Invasion via MAPK/ERK Pathway

SNORD11B-mediated 2′-O-methylation of primary let-7a in colorectal carcinogenesis

The SNORA21 Expression is Upregulated and Acts As a Novel Independent Indicator in Human Gastric Cancer Prognosis.

SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer

SNORA28 Promotes Proliferation and Radioresistance in Colorectal Cancer Cells through the STAT3 Pathway by Increasing H3K9 Acetylation in the LIFR Promoter

Involvement of the oncogenic small nucleolar RNA SNORA24 in regulation of p53 stability in colorectal cancer

SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis.

SnoRNA profiling in colorectal cancer and assessment of non-invasive biomarker capacity by ddPCR in fecal samples

SNORA70E Promotes the Occurrence and Development of Ovarian Cancer Through Pseudouridylation Modification of RAP1B and Alternative Splicing of PARPBP

Prognostic Value of Small Nucleolar RNAs (snornas) for Colon Adenocarcinoma Based on RNA Sequencing Data.

Small Nucleolar RNAs in Head and Neck Squamous Cell Carcinomas

LncRNA SNHG16 Promotes Colorectal Cancer Proliferation by Regulating ABCB1 Expression Through Sponging Mir-214-3p

High-grade ovarian cancer associated H/ACA snoRNAs promote cancer cell proliferation and survival

SNORA42 Promote Oesophageal Squamous Cell Carcinoma Development Through Interacting With Dhx9